Thyroid Medication Recall 2021: Drug Called Back Over Low-Potency Risk In Hypothyroidism Treatment
05/03/21 AT 1:33 PM
Acella Pharmaceuticals has recalled for the third time a significant number of thyroid tablets because they may not be potent enough.
Acella first recalled several lots of its thyroid medication back in September 2020 because of a sub-potency issue and then again in late May 2020 because the medication was over potent, the Miami Herald noted.
In this recall, Acella has called back 35 lots of thyroid tablets that are under potent after it received 43 reports of “serious adverse events,” according to the notice posted by the Food and Drug Administration.